THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

Clinical trial NCT01341262 · COMPLETED

Trial details

NCT number: NCT01341262
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2002-03-01
Primary completion: 2007-10-01
Enrollment: 378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.